An integrated analytical strategy to decipher the metabolic profile of alkaloids in Compound Kushen injection based on UHPLC-ESI-QTOF/MSE
Authors:
- 3 April 2023
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 53 (4) , 248-259
Abstract
1. Compound Kushen injection (CKI) is a kind of sterilized water-soluble traditional Chinese medicine preparation that has been used for the clinical treatment of a variety of cancers (hepatocellular carcinoma, lung cancer, etc.) for nineteen years. However, to date, the metabolism-related study on CKI in vivo has not been conducted.2. An integrated analytical strategy was established to investigate the metabolic profile of alkaloids of CKI in rat plasma, urine and feces based on ultra-high performance liquid chromatography-electrospray quadrupole time-of-flight mass spectrometry in MSE mode (UHPLC-ESI-QTOF/MSE).3. Nineteen prototype alkaloids (including 12 matrine-type alkaloids, 2 cytisine-type alkaloids, 3 lupinine-type alkaloids, and 2 aloperine-type alkaloids) of CKI were identified in vivo. Furthermore, seventy-one metabolites of alkaloids (including 11 of lupanine-related metabolites, 14 of sophoridine-related metabolites, 14 of lamprolobine-related metabolites and 32 of baptifoline-related metabolites) were tentatively characterized. Metabolic pathways involved in the metabolism of phase I (include oxidation, reduction, hydrolysis, and desaturation), phase II (mainly include glucuronidation, acetylcysteine or cysteine conjugation, methylation, acetylation and sulfation) and associated combination reactions.4. The integrated analytical strategy was successfully used to characterize the prototype alkaloids and their metabolites in CKI, and the results laying a foundation for further study its pharmacodynamic substances in vivo.Keywords
Funding Information
- National Natural Science Foundation of China (81903765)
- Natural Science Fund of Anhui Provincial Department of Education (KJ2018A171, 2022AH050444)
- Natural Science Fund of Anhui Province (1908085MH270)
- Research Fund of Anhui Institute of Translational Medicine (2021zhyx-C18)
This publication has 35 references indexed in Scilit:
- Efficacy and Safety of Compound Kushen Injection on Patients with Advanced Colon Cancer: A Meta‐Analysis of Randomized Controlled TrialsEvidence-Based Complementary and Alternative Medicine, 2017
- An untargeted metabolomics-driven approach based on LC–TOF/MS and LC–MS/MS for the screening of xenobiotics and metabolites of Zhi-Zi-Da-Huang decoction in rat plasmaJournal of Pharmaceutical and Biomedical Analysis, 2015
- Anti-tumor activities of active ingredients in Compound Kushen InjectionActa Pharmacologica Sinica, 2015
- Efficacy of Compound Kushen Injection in Relieving Cancer-Related Pain: A Systematic Review and Meta-AnalysisEvidence-Based Complementary and Alternative Medicine, 2015
- High‐resolution chromatography/time‐of‐flight MS E with in silico data mining is an information‐rich approach to reactive metabolite screeningRapid Communications in Mass Spectrometry, 2011
- Fragmentation pathways of drugs of abuse and their metabolites based on QTOF MS/MS and MSE accurate‐mass spectraJournal of Mass Spectrometry, 2011
- Oxymatrine induces human pancreatic cancer PANC-1 cells apoptosis via regulating expression of Bcl-2 and IAP families, and releasing of cytochrome cJournal of Experimental & Clinical Cancer Research, 2011
- Enhanced metabolite identification with MS E and a semi‐automated software for structural elucidationRapid Communications in Mass Spectrometry, 2010
- MS E with mass defect filtering for in vitro and in vivo metabolite identificationRapid Communications in Mass Spectrometry, 2007
- Metabolite Characterization in Drug Discovery Utilizing Robotic Liquid- Handling, Quadruple Time-of-Flight Mass Spectrometry and In-Silico PredictionCurrent Drug Metabolism, 2003